Clinical Trial Update: A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C [Phase 1, Phase 2]

View source ↗

Summary

The document is a clinical trial update for an early-stage safety and efficacy study of istaroxime in cardiogenic shock (Phase 1/Phase 2) conducted by Windtree …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• Istaroxime (istaroxime)

Snippet

Sponsor: Windtree Therapeutics | Conditions: Cardiogenic Shock | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING